79157292
Oct 1, 2014
Sep 15, 2015
OCTAPHARMA AG
Subscribe
Pharmaceutical products, namely, factor VIII preparations obtained from human blood plasma for prophylaxis and treatment of bleeding in patients with haemophilia A